ERK5 signalling in prostate cancer promotes an invasive phenotype. - Test2 - elhamkhani - TriplyDB

ERK5 signalling in prostate cancer promotes an invasive phenotype.

ERK5 signalling in prostate cancer promotes an invasive phenotype.

http://www.wikidata.org/entity/Q34627879

about

ERK5 and Cell Proliferation: Nuclear Localization Is What Matters Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer.A novel high throughput invasion screen identifies host actin regulators required for efficient cell entry by Toxoplasma gondii.MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin.MEK5 overexpression is associated with the occurrence and development of colorectal cancer Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.ERK5 negatively regulates tobacco smoke-induced pulmonary epithelial-mesenchymal transition.Role of MAPK7 in cell proliferation and metastasis in ovarian cancer Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer A comparison of epithelial-to-mesenchymal transition and re-epithelialization Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production.miR-139-5p is a regulator of metastatic pathways in breast cancer.Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.ERK5 and its role in tumour development.MiR-139-5p: promising biomarker for cancer.Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach Oncogenic signaling of MEK5-ERK5.Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation.Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity.WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7.Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.Curcumin Suppresses MAPK Pathways to Reverse Tobacco Smoke-induced Gastric Epithelial-Mesenchymal Transition in Mice.

P2860

Q28078572-5B981684-C550-4B11-8006-BD8DF19502BF Q28854310-238C07B9-3D7B-4EA9-B0BA-5E7B64032478 Q33851800-49398B3E-8E4B-46B2-87A3-01642994CE92 Q34212935-E23A406F-0E22-4C59-AF8C-9ACA34644F89 Q34760706-6B3C68B4-B15C-483F-8F48-E1A26DB91703 Q35560430-98823C09-E7AC-4E2C-85AD-15F56D654FFD Q35853880-4A1C1910-98A0-471F-A98E-F36343B5BACA Q36012573-10DC3170-E45E-41B1-AB6A-ED48692FD3B4 Q36173081-2FBAA89F-A83E-41B0-8626-E885AE0AC8DE Q36260600-53B6A2F0-3B3A-47D2-AD56-7B2D2BBA77DB Q36261403-70AAEAFD-A84D-4FCC-B4CF-29BBC6A1BE98 Q36293295-F6A9095D-6E65-4457-B9AC-17374DC49F14 Q36557814-B5084E82-F53D-40ED-9F9A-5308DAD47D82 Q36678367-D52E11B4-C2BB-406F-8164-25C1A5F37EE1 Q37388754-CD14E332-4C0B-400A-8EB8-7ED7C17376FE Q37448717-2ECA2C27-FA16-4C10-950C-DB4D77812F4E Q37556126-2A9FC03A-CE0D-45CE-AA0F-ED8E0FBC6E28 Q37977186-C73C2125-C6CD-413F-B090-06049E8D3723 Q38359431-DE2D853C-6EF6-4077-AE8D-E11D0AC73AB3 Q38767469-7BEBEB4B-3E18-4837-B544-311CF7B15B5D Q38828361-7704F891-76D2-4544-BC22-5B1AE3400D73 Q38849399-27407EEE-5F9B-4A0B-AB9D-9DBE08CAFF1E Q39116456-3A04BC0E-A4C6-4B52-B2AF-F1812F308202 Q39450541-79C67C46-2448-408B-9506-F23948C0F8C9 Q41033728-BBDE6D4D-043E-4DBE-A438-86878703578B Q41643520-E82A7237-E528-49C5-A9D5-AE4F3F816899 Q42051316-6FA2861F-B699-4308-928A-F541653015B3 Q42378808-0EDFAA89-A42D-4EF5-9126-28E6C04F8F34 Q42778113-CDA3D338-EB8F-4497-BC10-657C42153BCA Q49798105-E21996BA-3C06-4B6A-AB52-509956D5A43C Q51164416-EF0831A4-8E98-47E1-B84C-3EFDE36CCFD7 Q51337382-45228F30-AA05-4C0F-BA58-98E74FD6813D Q54265781-9D6348AC-8650-484E-8386-F9A8E0FD4DDA

P2860

ERK5 signalling in prostate cancer promotes an invasive phenotype.

http://www.wikidata.org/entity/Q34627879

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@ast

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@en

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@nl

type

label

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@ast

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@en

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@nl

prefLabel

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@ast

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@en

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@nl

P1433

Q34627879-531B8461-2934-4208-A0A7-3FFEA266F70A

P1476

Q34627879-BF14AC5B-6284-4AAA-A4C0-5A1B143AE206

P2093

Q34627879-0F03202D-2FED-4D9B-9FD3-E0CA163CCE6B

Q34627879-1C559E6C-A4BA-4448-B3A8-63011C21659A

Q34627879-249389B1-8130-4706-B16B-81419C34569E

Q34627879-4589F8BC-B350-48DD-9246-0B4130DE0C50

Q34627879-46B5162C-41AF-4DCE-82E2-2A66FF83FE10

Q34627879-5DF5FABB-7045-4186-8BA0-6F475CF972E8

Q34627879-94EFA51F-407A-4986-AAC5-67C9D4560969

Q34627879-99EF78A9-AB44-4E94-94C7-4BD5C3A0314C

Q34627879-A90BBD10-4C1E-4088-9EDD-96B28E569A95

Q34627879-C39E66FA-F29F-4B17-9B18-DB2A584E833C

P2860

Q34627879-0FFC1AD2-190D-419D-9535-F12EBD4A4502

Q34627879-18B3CADB-FC21-4A52-B46B-5C88A929FDE1

Q34627879-1971C0B4-1FD0-4278-9D00-3BD19055A674

Q34627879-2352C892-A5A2-45B6-A9BF-D9E5D12FF2BC

Q34627879-305A353E-EC90-4052-97E6-E18623879E67

Q34627879-398560D3-13CA-4ADD-B9DC-4F1F44F781D5

Q34627879-4EC2F24A-F236-4DF2-A226-63B284E06EFE

Q34627879-6F5F29DB-A12D-492A-8F37-7D45D67C9494

Q34627879-7444A2B2-DB80-44F5-B341-3428DEAD4F9D

Q34627879-757B9E22-9748-4F44-ABB5-C333430D211C

P2888

Q34627879-C11388AB-B801-44D5-B148-E223E7FB0BE4

P304

Q34627879-7A3602E2-2E5F-4E8F-97B4-972A6D252DD0

P31

Q34627879-3003A70F-85C4-4EDB-A4F4-32460413FCB7

P356

Q34627879-3DDD362E-75DE-4853-BE37-4106E3215E20

P407

Q34627879-443BC153-AA7F-4C82-8F2D-B783495D1A13

P433

Q34627879-438597C4-E73C-4020-82CC-715C9E7EB2D0

P478

Q34627879-38500CBE-A21E-423C-9268-2C393412DAB8

P50

Q34627879-0BF80EC3-B4CD-4BA2-B888-EDC95A728462

P577

Q34627879-5C83336D-BB20-4DEE-8F27-DC7FD6078408

P5875

Q34627879-01ED7B9C-2782-4F2B-851B-CCBAB94B27F4

P6179

Q34627879-C2C861CD-D715-4964-8A64-D42FCD1FD0CF

P698

Q34627879-1F68BF4F-2980-4593-8990-D563AF46ACA5

P932

Q34627879-7FB7EDF0-4B37-431F-8DFB-F2665B6298B7

P356

P1433

British Journal of Cancer

P1476

ERK5 signalling in prostate cancer promotes an invasive phenotype.

@en

P2093

A K Ramsay

http://www.w3.org/2001/XMLSchema#string

A X Yu

http://www.w3.org/2001/XMLSchema#string

C Nixon

http://www.w3.org/2001/XMLSchema#string

D R Edwards

http://www.w3.org/2001/XMLSchema#string

E Keller

http://www.w3.org/2001/XMLSchema#string

H Y Leung

http://www.w3.org/2001/XMLSchema#string

I Ahmad

http://www.w3.org/2001/XMLSchema#string

L Machesky

http://www.w3.org/2001/XMLSchema#string

M Seywright

http://www.w3.org/2001/XMLSchema#string

M Soofi

http://www.w3.org/2001/XMLSchema#string

P2860

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice

Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C

Basic local alignment search tool

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Mammalian MAP kinase signalling cascades

Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway

Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration

New functions for the matrix metalloproteinases in cancer progression

P2888

P304

664-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6606062

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Sarah J Fleming

P577

2011-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49785419

http://www.w3.org/2001/XMLSchema#string

P6179

1026744928

http://www.w3.org/2001/XMLSchema#string

P698

21266977

http://www.w3.org/2001/XMLSchema#string

P932

3049582

http://www.w3.org/2001/XMLSchema#string